Valens and BRNT Enter Into Major White Label Deal With a Gross Revenue Potential to Valens of More Than $50 Million On October 30, 2019October 30, 2019
Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019 On October 15, 2019October 15, 2019
Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019 On October 9, 2019October 9, 2019
Valens Announces Results of Annual General and Special Meeting of Shareholders On September 24, 2019September 24, 2019
Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational Update On September 23, 2019September 23, 2019
Valens Announces Record Third Quarter 2019 Revenue Guidance and Participation in Live Investor Webcast on September 12th On September 10, 2019September 10, 2019